Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07675018 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

INterest of the Negative Predictive Value of Integrons in the reduCtion of Large Broad-spectrum anTibiotics Consumption for Urinary Tract infectionS

Study acronym: INVICTUS
StatusNot Yet Recruiting
PhaseNot applicable
Started2026-09-15
View on ClinicalTrials.gov ↗

Amendment history

2026-06-29
minor
Study Identification, Study Status, Study Description v1
Study description-37 characters
WeThe promotor conducted a multicenter prospective study, IRIS (Interest o [...] gh negative predictive value (NPV) for antibiotic resistance (Barraud O et al. J Antimicrob Chemother 2021). Among the 343 patients admitted in the ED or intensive care [...]
Study title-20 characters
[...] pectrum anTibiotics Consumption for Urinary Tract infectionS: a Randomized Trial
2026-06-23
minor
Original filing
Urinary tract infections (UTI), mainly driven by Gram-negative bacteria (GNB) are a frequent cause of hospitalization and the second cause of antibiotic prescription after lower respiratory tract infections. Integrons play a major role in the dissemination of antibiotic resistance among GNB. In the prospective INVICTUS project, whose ultimate objective is to reduce the use of large broad-spectrum antibiotics, our hypothesis is that, in adult patients with a non-severe UTI (qSOFA\<2) and a former documentation with a 3GC-resistant GNB in the previous 6 months, integrons search could reduce the empirical use of large broad-spectrum antibiotics.
Trial Details
NCT Number NCT07675018
Lead Sponsor University Hospital, Limoges
Conditions Drug Resistance, Microbial, Biomarkers, Urinary Tract Infections (UTI's), Antibacterial Agents
Enrollment 204 participants
Start Date 2026-09-15
Primary Completion 2028-09-21 (estimated)
Study Completion 2028-09-21 (estimated)
Updated on ClinicalTrials.gov 2026-07-01